Target intelligence / Profile preview

novel transcript, antisense to ZMIZ1 (ENSG00000294199)

Target
ENSG00000294199
Molecular classification
Other (antisense non-coding RNA)
01

Overview

This entry refers to an uncharacterized, likely non-coding RNA transcript that is transcribed in the antisense orientation relative to the ZMIZ1 gene. Such antisense transcripts are sometimes annotated in genome databases based on transcriptomics data, but they typically lack experimental validation or well-established biological functions. There is currently no evidence that ENSG00000294199 encodes a protein or acts as a receptor, enzyme, transporter, or therapeutic target. In general, antisense RNAs may regulate the expression of their overlapping sense genes through mechanisms like transcriptional interference, RNA duplex formation, or chromatin remodeling, but no such function is confirmed here. ZMIZ1 (Zinc Finger MIZ-Type Containing 1) itself is a well-characterized transcriptional coactivator involved in numerous biological processes, including transcription regulation, lymphatic endothelial cell biology, and neurodevelopmental diseases. The antisense transcript described here is distinct from the protein-coding ZMIZ1 gene and does not appear in disease, drug, or target discovery resources as a standalone entity. This transcript should not be treated as a canonical therapeutic target or receptor, and its entry is only relevant as a genomic annotation artifact, not as a recognized molecule for pharmacological or disease-modifying intervention purposes.

Other names
antisense transcript to ZMIZ1
02

Biological functions

No experimentally confirmed biological functionMay regulate gene expression at the transcriptional or post-transcriptional level (general for antisense transcripts)

Beyond the preview

Go deeper on novel transcript, antisense to ZMIZ1 (ENSG00000294199).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to ZMIZ1 (ENSG00000294199).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call